美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 11 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| REGADENOSON |
207604 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/04/11
|
2022/04/11
|
APOTEX |
Prescription |
| REGADENOSON |
212806 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/04/11
|
2022/04/11
|
MEITHEAL |
Prescription |
| REGADENOSON |
213210 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/04/11
|
2022/04/11
|
DR REDDYS |
Prescription |
| REGADENOSON |
213236 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/04/11
|
2022/04/11
|
ACCORD HLTHCARE |
Prescription |
| REGADENOSON |
214252 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/05/23
|
2022/05/23
|
IMS LTD |
Prescription |
| REGADENOSON |
207320 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/07/12
|
2022/07/12
|
GLAND PHARMA LTD |
Prescription |
| REGADENOSON |
214349 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/08/31
|
2022/08/31
|
HOSPIRA |
Prescription |
| REGADENOSON |
216437 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2022/10/26
|
2022/10/26
|
EUGIA PHARMA |
Prescription |
| REGADENOSON |
215827 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2023/02/02
|
2023/02/02
|
HIKMA |
Prescription |
| REGADENOSON |
213856 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2023/04/04
|
2023/04/04
|
MYLAN |
Prescription |
| REGADENOSON |
217455 |
001 |
ANDA |
REGADENOSON |
SOLUTION;INTRAVENOUS |
0.4MG/5ML (0.08MG/ML) |
No
|
No
|
2023/05/23
|
2023/05/23
|
BAXTER HLTHCARE CORP |
Prescription |